Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3.

Ohashi, Ryuji; Namimatsu, Shigeki; Sakatani, Takashi; Naito, Zenya; Takei, Hiroyuki; Shimizu, Akira

Ohashi, Ryuji; Namimatsu, Shigeki; Sakatani, Takashi; Naito, Zenya; Takei, Hiroyuki; Shimizu, Akira.

Afiliación

Ohashi R; Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan.
Namimatsu S; Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan.
Sakatani T; Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan.
Naito Z; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.
Takei H; Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan.
Shimizu A; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.

J Surg Oncol ; 118(3): 557-567, 2018 Sep.

Article en En | MEDLINE | ID: mdl-30098295

Asunto(s)

Neoplasias de la Mama/patología; Histonas/metabolismo; Antígeno Ki-67/metabolismo; Mitosis; Índice Mitótico; Adulto; Anciano; Anciano de 80 o más Años; Biomarcadores de Tumor; Neoplasias de la Mama/metabolismo; Neoplasias de la Mama/cirugía; Femenino; Estudios de Seguimiento; Humanos; Persona de Mediana Edad; Fosforilación; Pronóstico; Tasa de Supervivencia

Palabras clave

Ki67; atypical mitoses; biomarkers; breast cancer; phosphohistone H3

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Histonas / Antígeno Ki-67 / Mitosis / Índice Mitótico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: J Surg Oncol Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google